Talk to us

Recent blog posts

The spark behind Immuneed. An interview with founder Sara Mangsbo.

"How do we characterize the effects of cascade systems when a drug meets the blood and its cells, could we get a more holistic picture? That was really the start." Follow the link to read the story behind Immuneed and why our global clients are so intrigued about our platform.

Could platelets block your drug's path to success?

Platelets do far more than halt the flow of blood. So how might they interact with your drug candidate? Intentionally or unintentionally, a drug that triggers platelet activity unfolds a dramatic chain of events.

Which questions should we be asking in preclinical testing?

Immuneed Chief Operating Officer share first-hand experience from taking a drug candidate from preclinical testing to first in human trials - without testing on animals. "It was clear from the outset that safety testing on mice would have no relevance for our drug’s potential to succeed in humans. Nonetheless, many said it would...